IRISIN AS A NOVEL DIAGNOSTIC BIOMARKER FOR INFLAMMATORY DISEASES: A REVIEW
DOI:
https://doi.org/10.55519/JAMC-03-12344Keywords:
Diagnostic biomarkers, Inflammatory diseases, Salivary irisin, Serum irisinAbstract
Background: Inflammatory biomarkers are molecules that can offer vital information on the intricate chain of happenings and molecular processes underpinning the pathophysiology of any inflammatory disease. They can be measured in various biological samples such as blood, urine, or saliva, and are used as indicators of the presence and severity of inflammation. Measuring salivary inflammatory biomarkers is a non-invasive and relatively easy way to monitor inflammation, and it has been shown to be a useful tool in the diagnosis and management of various oral and systemic inflammatory diseases. Irisin is a novel anti-inflammatory protein and its implication and diagnostic role in inflammation have been widely studied; however, not much have been studied in oral inflammation per se. Irisin is predominantly downregulated in several inflammatory conditions, including obesity, type 2 diabetes, periodontitis, and cardiovascular diseases. This suggests that irisin may be involved in the inflammatory process, but more research is needed, especially of salivary irisin to understand its precise role. Overall, the role of irisin as an inflammatory biomarker is still an area of active research, and more studies are needed to determine its diagnostic and therapeutic potential. This review highlights the diagnostic and therapeutic potential of irisin in various systemic and oral inflammatory conditions.
References
Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood) 2018;243(3):213-21.
Srinitha B. Biomarkers and Disease Diagnosis. Prim Health Care Open Access 2021;11(4):1-2.
Byrnes SA, Weigl BH. Selecting analytical biomarkers for diagnostic applications: a first principles approach. Expert Rev Mol Diagn 2018;18(1):19-26.
Mazur-Bialy AI. Irisin acts as a regulator of macrophages host defense. Life Sci 2017;176:21-5.
Mazur-Bialy AI, Kozlowska K, Pochec E, Bilski J, Brzozowski T. Myokine irisin-induced protection against oxidative stress in vitro. Involvement of heme oxygenase-1 and antioxidazing enzymes superoxide dismutase-2 and glutathione peroxidase. J Physiol Pharmacol 2018;69(1):117-25.
Korta P, Pochec E, Mazur-Bialy A. Irisin as a Multifunctional Protein: Implications for Health and Certain Diseases. Medicina (Kaunas) 2019;55(8):485.
Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481(7382):463-8.
Aydin S, Kuloglu T, Aydin S, Eren MN, Celik A, Yilmaz M, et al. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides 2014;52:68-73.
Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab 2013;18(5):649-59.
Khan SU, Ghafoor S. Myokines: Discovery Challenges and Therapeutic Impediments. J Pak Med Assoc 2019;69(7):1014-7.
Missaglia S, Tommasini E, Vago P, Pecci C, Galvani C, Silvestrini A, et al. Salivary and serum irisin in healthy adults before and after exercise. Eur J Transl Myol 2023;33(1):11093.
Chen N, Li Q, Liu J, Jia S. Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review. Diabetes Metab Res Rev 2016;32(1):51-9.
Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models. Nat Med 2019;25(1):165-75.
Saeedi Sadr A, Ehteram H, Seyed Hosseini E, Alizadeh Zarei M, Hassani Bafrani H, Haddad Kashani H. The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines. Oncol Ther 2022;10(2):377-88.
Morgan EN, Alsharidah AS, Mousa AM, Edrees HM. Irisin Has a Protective Role against Osteoporosis in Ovariectomized Rats. Biomed Res Int 2021;2021:5570229.
Pan JA, Zhang H, Yu Q, Zhang JF, Wang CQ, Gu J, et al. Association of Circulating Irisin Levels and the Characteristics and Prognosis of Coronary Artery Disease. Am J Med Sci 2021;362(1):63-71.
Liu L, Guo J, Chen X, Tong X, Xu J, Zou J. The Role of Irisin in Exercise-Mediated Bone Health. Front Cell Dev Biol 2021;9:668759.
Mazur-Bialy AI, Pocheć E, Zarawski M. Anti-Inflammatory Properties of Irisin, Mediator of Physical Activity, Are Connected with TLR4/MyD88 Signaling Pathway Activation. Int J Mol Sci 2017;18(4):701.
Liu CH, Abrams ND, Carrick DM, Chander P, Dwyer J, Hamlet MRJ, et al. Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities. Nat Immunol 2017;18(11):1175-80.
Ansar W, Ghosh S. Inflammation and Inflammatory Diseases, Markers, and Mediators: Role of CRP in Some Inflammatory Diseases. Biol C React Protein Health Dis 2016;2016:67-107.
Dieterle MG, Putler R, Perry DA, Menon A, Abernathy-Close L, Perlman NS, et al. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection. mBio 2020;11(3):e00180.
Byun K, Lee S. The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review. Int J Mol Sci 2020;21(19):7184.
Fu J, Li F, Tang Y, Cai L, Zeng C, Yang Y, et al. The Emerging Role of Irisin in Cardiovascular Diseases. J Am Heart Assoc 2021;10(20):e022453.
Buscemi S, Corleo D, Vasto S, Buscemi C, Barile AM, Rosafio G, et al. Serum Irisin Concentrations in Severely Inflamed Patients. Horm Metab Res 2020;52(4):246-50.
Yao Z, Ding X, Gao X, Yang N, Jia Y, Liu J, et al. Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism. Int J Endocrinol 2021;2021:3116068.
Kulhan NG, Kulhan M, Turkler C, Ata N, Kiremitli T, Kiremitli S. Could serum levels of irisin be used in gestational diabetes predicting? Taiwan J Obstet Gynecol 2019;58(3):434-7.
Shim YS, Kang MJ, Yang S, Hwang IT. Irisin is a biomarker for metabolic syndrome in prepubertal children. Endocr J 2018;65(1):23-31.
Ambrogio F, Sanesi L, Oranger A, Barlusconi C, Dicarlo M, Pignataro P, et al. Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis. Biomolecules 2022;12(8):1096.
Mustafa AI, El-Shimi OS. Serum irisin: A prognostic marker for severe acne vulgaris. J Cosmet Dermatol 2018;17(5):931-4.
Altay DU, Korkmaz M, Ergun S, Korkmaz H, Noyan T. Salivary irisin: potential inflammatory biomarker in recurrent apthous stomatitis patients. Eur Rev Med Pharmacol Sci 2021;25(5):2252-9.
Turkmen E, Uzun EV, Bozaba F, Balci N, Toygar H. Salivary irisin level is higher and related with interleukin-6 in generalized periodontitis. Clin Oral Investig 2023;27(6):3001-8.
Hisamatsu T, Miura K, Arima H, Fujiyoshi A, Kadota A, Kadowaki S, et al. Relationship of serum irisin levels to prevalence and progression of coronary artery calcification: A prospective, population-based study. Int J Cardiol 2018;267:177-82.
Aslan R, Alp HH, Eryılmaz R, Huyut Z, Sevim M, Araz Ş, et al. Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study. Asian Pac J Cancer Prev 2020;21(2):505-9.
Wozniak S, Nowinska K, Chabowski M, Dziegiel P. Significance of Irisin (FNDC5) Expression in Colorectal Cancer. In Vivo 2022;36(1):180-8.
Lourenco MV, Ribeiro FC, Sudo FK, Drummond C, Assunção N, Vanderborght B, et al. Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer's disease. Alzheimers Dement (Amst) 2020;12(1):e12034.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sadia Rana, Norsila Abdul Wahab, Wan Nazatul Shima Shahidan, Saira Atif, Ayesha Fahim
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
